glp-1 and eye issues Frontiers glp-1 dry eyes As the

PlexusDx supports precision wellness by helping you understand how your genetic background in GLP-1 and metabolic pathways may influence which interactions carry the most clinical relevance for your unique biology

: - ( )

Current Medicinal Chemistry , 13(15):1749-55 Fraternale, A., Brundu, S

Noom expands its GLP-1 range with 'microdose' package Digital health company Noom has started offering lower doses of GLP-1 agonist semaglutide, the active ingredient in Novo Nordisk's weight-loss drug Wegovy, at a knock-down price

Efficacy and safety of once-weekly semaglutide 2.4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial